Physician profile
Amy Matherne
NPI 1962800821
$1,047.75
in general payments reported to CMS, 2019-2025
13 companies · $71.53 in 2025
The $71.53 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $255 · 2021: $68.59 · 2022: $101 · 2023: $126 · 2024: $42.03 · 2025: $71.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $408.71 | 2019-2025 | Onyda Xr |
| Ironshore Pharmaceuticals INC. | $146.31 | 2019-2020 | |
| Pfizer INC. | $88.86 | 2019-2023 | |
| Corium, LLC | $79.14 | 2022-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $59.04 | 2019-2023 | Vaxneuvance, Gardasil 9 |
| Genentech USA, INC. | $58.26 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.48 | 2020 | |
| Cranial Technologies, INC | $43.74 | 2024-2025 | Doc Band |
| Phadia US INC. | $41.66 | 2019-2024 | Immunocap |
| Ucb, INC. | $30.94 | 2023 | Briviact |
| Qiagen, LLC | $17.68 | 2021 | |
| Hologic Sales and Service, LLC | $16.65 | 2021 | |
| Almirall LLC | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Matherne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.